| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |